Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 6
Submit an article Journal homepage
514
Views
22
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Phase II study of 90Y Ibritumomab tiuxetan (Zevalin) in patients with previously untreated marginal zone lymphoma

Izidore S. LossosDivision of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA;Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence[email protected]
,
Jesus C. FabregasDivision of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA;Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
,
Tulay Koru-SengulSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA;Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA
,
Feng MiaoSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
,
Deborah GoodmanSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
,
Aldo N. SerafiniSylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA;Department of Radiology, University of Miami Miller School of Medicine, Miami, FL, USA
,
Peter J. HoseinDivision of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA;Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
,
Alexandra StefanovicDivision of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA;Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
,
Joseph D. RosenblattDivision of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA;Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
&
James E. HoffmanDivision of Hematology/Oncology, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, USA;Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA
 show all
Pages 1750-1755 | Received 15 Jul 2014, Accepted 06 Oct 2014, Published online: 20 Nov 2014

Citations (22)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Thomas A Ollila & Adam J Olszewski. (2021) Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma. Cancer Management and Research 13, pages 3935-3952.
Read now
Izidore S. Lossos, Isildinha M. Reis, Joseph D. Rosenblatt & Juan Pablo Alderuccio. (2020) Long-term outcomes of frontline 90Y-ibritumomab tiuxetan in marginal zone lymphoma. Leukemia & Lymphoma 61:13, pages 3234-3238.
Read now

Articles from other publishers (20)

Muhamad Alhaj Moustafa, Bijan J. Borah, James P. Moriarty, Ruchita Dholakia, Liuyan Jiang, Ke Li, Thomas E. Witzig, Bradford S. Hoppe, Jennifer Peterson, James R. Cerhan & Han W Tun. (2023) Yttrium-90 Ibritumomab Tiuxetan is Cost-Effective Compared to Bendamustine + Rituximab in Low-grade Lymphomas. Clinical Lymphoma Myeloma and Leukemia 23:4, pages 259-265.
Crossref
Daniel Tseng, Spencer Shao & Tris Arscott. 2023. The AFS Textbook of Foregut Disease. The AFS Textbook of Foregut Disease 507 515 .
Dominic Kaddu-Mulindwa, Lorenz Thurner, Konstantinos Christofyllakis, Moritz Bewarder & Igor Age Kos. (2022) Management of Extranodal Marginal Zone Lymphoma: Present and Upcoming Perspectives. Cancers 14:12, pages 3019.
Crossref
Alice Di Rocco, Luigi Petrucci, Giovanni Manfredi Assanto, Maurizio Martelli & Alessandro Pulsoni. (2022) Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment. Cancers 14:7, pages 1742.
Crossref
Michael Herold, Eva Hoster, Ann Janssens, Helen McCarthy, Alessandra Tedeschi, Chris Pocock, Andras Rosta, Marek Trněný, Tina G. Nielsen, Andrea Knapp, Wolfgang Hiddemann & Robert Marcus. (2022) Immunochemotherapy and Maintenance With Obinutuzumab or Rituximab in Patients With Previously Untreated Marginal Zone Lymphoma in the Randomized GALLIUM Trial. HemaSphere 6:3, pages e699.
Crossref
Arif Sheikh, Shazia Fatima, Zain Khurshid & Zaheer Chiragh. 2022. Nuclear Medicine and Immunology. Nuclear Medicine and Immunology 359 432 .
Aurélie Rondon, Jacques Rouanet & Françoise Degoul. (2021) Radioimmunotherapy in Oncology: Overview of the Last Decade Clinical Trials. Cancers 13:21, pages 5570.
Crossref
Luca Arcaini & Andreas Viardot. 2021. Indolent Lymphomas. Indolent Lymphomas 117 125 .
Alessandro Broccoli & Pier Luigi Zinzani. (2020) How do we sequence therapy for marginal zone lymphomas?. Hematology 2020:1, pages 295-305.
Crossref
Mengyang Di, Thomas A. Ollila & Adam J. Olszewski. (2020) Exposure to ibritumomab tiuxetan and incidence of treatment-related myeloid neoplasms among older patients with B-cell lymphoma: a population-based study. Leukemia 34:10, pages 2794-2797.
Crossref
Ginevra Lolli, Lisa Argnani, Alessandro Broccoli, Miriam Marangon, Cinzia Pellegrini, Alice Morigi, Beatrice Casadei, Laura Nanni, Vittorio Stefoni, Matteo Carella, Michele Cavo & Pier L. Zinzani. (2020) 90 Y‐ibritumomab tiuxetan in patients with extra‐nodal marginal zone B‐cell lymphoma of mucosa‐associated lymphoid tissue (MALT lymphoma) — The Zeno Study . British Journal of Haematology 189:1.
Crossref
Rebecca E. Tanenbaum, Anat Galor, Sander R. Dubovy & Carol L. Karp. (2019) Classification, diagnosis, and management of conjunctival lymphoma. Eye and Vision 6:1.
Crossref
Ariel Sindel, Taha Al-Juhaishi & Victor Yazbeck. (2019) Marginal Zone Lymphoma: State-of-the-Art Treatment. Current Treatment Options in Oncology 20:12.
Crossref
Melody R. Becnel, Loretta J. Nastoupil, Felipe Samaniego, Richard E. Davis, M. J. You, Michael Green, Fredrick B. Hagemeister, Michelle A. Fanale, Luis E. Fayad, Jason R. Westin, Michael Wang, Yasuhiro Oki, Sheryl G. Forbes, Lei Feng, Sattva S. Neelapu & Nathan H. Fowler. (2019) Lenalidomide plus rituximab (R 2 ) in previously untreated marginal zone lymphoma: subgroup analysis and long‐term follow‐up of an open‐label phase 2 trial . British Journal of Haematology 185:5, pages 874-882.
Crossref
Yazid Belkacemi, Terence T. Sio, Laurianne Colson-Durand, Cem Onal, Salvador Villà, Yavuz Anacak, Marco Krengli, Juliette Thariat, Gamze Ugurluer, Robert C. Miller, René-Olivier Mirimanoff, Mahmut Ozsahin & Nhu Hanh To. (2019) Primary extranodal lymphoma of the glands. Literature review and options for best practice in 2019. Critical Reviews in Oncology/Hematology 135, pages 8-19.
Crossref
Dimitrios Kalogeropoulos, Alexandra Papoudou-Bai, Panagiotis Kanavaros & Chris Kalogeropoulos. (2017) Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue. Clinical and Experimental Medicine 18:2, pages 151-163.
Crossref
Davinia Ryan & Lisa Bodei. (2017) Radioimmunotherapy in Oncology. Current Radiology Reports 5:12.
Crossref
Marianna Sassone, Maurilio Ponzoni & Andrés J.M. Ferreri. (2017) Ocular adnexal marginal zone lymphoma: Clinical presentation, pathogenesis, diagnosis, prognosis, and treatment. Best Practice & Research Clinical Haematology 30:1-2, pages 118-130.
Crossref
Tamar Tadmor & Aaron Polliack. (2017) Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment. Best Practice & Research Clinical Haematology 30:1-2, pages 92-98.
Crossref
Pier Luigi Zinzani & Alessandro Broccoli. (2017) Possible novel agents in marginal zone lymphoma. Best Practice & Research Clinical Haematology 30:1-2, pages 149-157.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.